Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novabay Pharmaceuticals
(NY:
NBY
)
0.6298
+0.0398 (+6.75%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novabay Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 21, 2023
Via
Benzinga
NovaBay Pharmaceuticals Launches DERMAdoctor’s New Comfort + Joy Psoriasis Therapeutic Moisturizing Cream on the QVC® Network
April 21, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results
March 30, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Earnings Preview: NovaBay Pharmaceuticals
March 29, 2023
Via
Benzinga
Earnings Scheduled For March 30, 2023
March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
Via
Benzinga
NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023
March 23, 2023
From
NovaBay Pharmaceuticals, Inc:
Via
Business Wire
Eyeganics Organic Tears, the Only USDA-Certified Organic Lubricant Eye Drop, Now Available through NovaBay Pharmaceuticals’ Avenova.com and Physician-Dispensed Channel
March 14, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Launches Avenova® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health
March 07, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor’s Eczema Treatment on Two QVC® Shows on February 7
February 06, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023
January 31, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
PhaseOne Health and NovaBay Pharmaceuticals to Expand Commercial and Collaborative Strategies for the Wound Care Market
January 17, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 14, 2022
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and China
November 29, 2022
From
NovaBay® Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor’s Eczema Balm
November 17, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 14, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
November 17, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
On Wednesday, 70 companies set new 52-week lows.
Via
Benzinga
NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split
November 14, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
NovaBay Pharmaceuticals to Hold Third Quarter 2022 Conference Call on November 14
November 09, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum
October 26, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV
October 19, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
October 25, 2022
On Tuesday, 120 companies set new 52-week lows.
Via
Benzinga
NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctor’s Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season
October 18, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Why Missfresh Shares Are Trading Lower; Here Are 30 Stocks Moving Premarket
October 10, 2022
Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group,...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 10, 2022
We're starting off the trading week with a look at the biggest pre-market stock movers for Monday morning and the news moving them!
Via
InvestorPlace
NovaBay Pharmaceuticals’ Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale
October 10, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Low Share Price
October 07, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.